English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.
Tag: Cancer Treatments
Data detectives strike back at deadly childhood cancer
Neuroblastoma is a rare and aggressive form of childhood cancer. Striking in infancy, it shatters what should be a family’s time of joy, shifting it to a fight for survival. While the search for a cure continues, researchers at the University of South Australia are striving to decode the causes of neuroblastoma to inform new, less toxic treatment strategies for young patients.
New addition to standard-of-care treatments for non-small-cell lung cancer patients has potential to increase progression-free survival
Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly extend progression-free survival for patients with non-small-cell lung cancer (NSCLC), the most common type of lung cancer.
Botanical medicine reduces rectal cancer treatment side effects that can sideline surgeries
Ancient Chinese traditional medicine significantly reduces the side effects of rectal cancer treatments that, in some patients, can be so toxic that treatment must be paused, or stopped, which diminishes its effectiveness.
Yale Cancer Center experts present new research on obesity, tobacco, evolution, and early onset cancers at leading oncology conference
Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.
Montefiore Einstein Comprehensive Cancer Center Awarded Comprehensive Designation from the National Cancer Institute
The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI) of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S.
Research raises hopes for new treatment of fusion-driven cancer
A new study presents a promising treatment method for so-called fusion-driven cancers, which are currently often difficult to cure. These fusion-driven cancers are caused by an error in cell division that creates a fusion of different genes. This fusion causes the cancer and drives the uncontrolled cell growth.
Study identifies potential treatment target for prostate cancer resistant to hormone therapy
Prostate cancer is the most-commonly diagnosed malignancy and the second leading cause of cancer death among men in the United States. In its ever-indelicate world, the stubborn disease can continue to grow even when the amount of testosterone in the body is reduced to very low levels, thus earning the clumsy name: castrate-resistant prostate cancer (CRPC).
Researchers use Artificial Intelligence to personalise cancer patient treatments
Researchers at the University of Sussex are using Artificial Intelligence (AI) technology to analyse different types of cancer cells to understand different gene dependencies, and to identify genes that are critical to a cell’s survival.
Scientists develop new device to detect brain tumors using urine
Researchers at Nagoya University in Japan have used a new device to identify a key membrane protein in urine that indicates whether the patient has a brain tumor.
‘Molecular Twin’ Initiative Will Help Advance Precision Cancer Treatment
Cedars-Sinai Cancer and Tempus, a leader in artificial intelligence and precision medicine, are harnessing the power of big data and AI to design personalized cancer treatment options by creating virtual replicas of patients’ DNA, RNA, protein and other information to help identify the most effective approach to each individual’s disease.
New grant, National Fellowship for UA Little Rock Nanotechnology Researcher
Dr. K. Bao Vang-Dings, a nanotechnology researcher at the University of Arkansas at Little Rock, has been named one of nine 2021-22 Public Policy Fellows by the American Association of Immunologists. Additionally, the Arkansas IDeA Network of Biomedical Research Excellence (INBRE) has awarded her a 2021 Summer Research Grant to support Vang-Dings’ cancer vaccine research.
Henry Ford Health System Kicks Off David DiChiera Music Therapy Program with Detroit Symphony Orchestra and Michigan Opera Theatre
Henry Ford Health System, in partnership with the Detroit Symphony Orchestra (DSO) and Michigan Opera Theatre (MOT), has begun offering virtual musical performances to cancer patients via its music therapy program named for the founding general director of Michigan Opera Theatre, David DiChiera. Through the David DiChiera Music Therapy Program, patients of Henry Ford Cancer Institute will be able to enjoy both live and archived virtual performances from the DSO and MOT at no cost.
NUS researchers discover breakthrough in cancer diagnosis using big data analytics
A team of researchers from the National University of Singapore has developed a personalised assessment tool which can detect the incidence of cancer, predict patient survivability and determine patient suitability for immunotherapy cancer treatment.